# Octapharma Plasma Inc – FDA Inspection, Jan 10, 2024

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/d63e57ea-513c-434e-a7d3-dc4f6985146f
Source feed: FDA_Inspections

> FDA inspection 1227066 of Octapharma Plasma Inc, January 10, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1227066
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2024-01-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jennifer-l-sheehan/a49c628d-6eba-4b52-bafc-70785b9ba75e)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/1a23d319-a8d1-44c5-a19c-90efa35ef2f8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
